Literature DB >> 8480510

Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

M A Morán1, E J Mufson, P Gómez-Ramos.   

Abstract

The colocalization of beta amyloid protein with the enzymes acetyl- and butyrylcholinesterase was assessed using immunocytochemistry for beta amyloid protein and a sensitive histochemical technique for cholinesterases. In non-demented aged and Alzheimer's disease brains, double-stained sections for cholinesterases and thioflavin-S showed that all thioflavin-S-positive plaques were also positive for cholinesterases, indicating the presence of these enzymes in all plaques with beta-pleated amyloid protein. When amyloid angiopathy was present, cholinesterases were also observed in amyloid-laden vessels walls. Comparison of series of adjacent sections alternatively stained for acetylcholinesterase, beta amyloid protein and butyrylcholinesterase, as well as by double histo-immunocytochemical staining, showed either cholinesterase in a proportion of the preamyloid diffuse plaques. These data indicate that cholinesterases are associated with the amyloid protein from very early stages, when the beta-pleated structure is being formed. Novel functions attributed to acetyl- and butyrylcholinesterase, such us their proteolytic activity either by themselves or in association with heparan sulfate proteoglycans, may play a role in the aggregation or the consolidation processes taking place at the early stages of diffuse plaque formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480510     DOI: 10.1007/bf00334445

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  64 in total

1.  Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques.

Authors:  L Verga; B Frangione; F Tagliavini; G Giaccone; A Migheli; O Bugiani
Journal:  Neurosci Lett       Date:  1989-11-06       Impact factor: 3.046

2.  Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

Authors:  C R Abraham; T Shirahama; H Potter
Journal:  Neurobiol Aging       Date:  1990 Mar-Apr       Impact factor: 4.673

3.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

4.  Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.

Authors:  K A Carson; C Geula; M M Mesulam
Journal:  Brain Res       Date:  1991-02-01       Impact factor: 3.252

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization.

Authors:  S Nakamura; S Kawashima; S Nakano; T Tsuji; W Araki
Journal:  J Neural Transm Suppl       Date:  1990

7.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.

Authors:  P Gomez-Ramos; E J Mufson; M A Moran
Journal:  Brain Res       Date:  1992-01-13       Impact factor: 3.252

9.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

10.  Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.

Authors:  M M Mesulam; C Geula; M A Morán
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

View more
  31 in total

1.  Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Hiroyasu Akatsu; Eric E Abrahamson; Zhiping Mi; Milos D Ikonomovic
Journal:  Neuropathology       Date:  2015-08-21       Impact factor: 1.906

2.  Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease.

Authors:  Margarita C Dinamarca; Juan P Sagal; Rodrigo A Quintanilla; Juan A Godoy; Macarena S Arrázola; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2010-01-18       Impact factor: 14.195

3.  Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

Authors:  Y Li; L Liu; J Kang; J G Sheng; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 4.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

5.  Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.

Authors:  Bin Zhang; Sigrid C Veasey; Marcelo A Wood; Lewis Z Leng; Christine Kaminski; Susan Leight; Ted Abel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.

Authors:  Jing Yang; Yong Ji; Pankaj Mehta; Kristyn A Bates; Yanjie Sun; Thomas Wisniewski
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.

Authors:  M A Morán; E J Mufson; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.

Authors:  Haiheng Dong; Yun-Yan Xiang; Noa Farchi; William Ju; Yaojiong Wu; Liwen Chen; Yutian Wang; Binyamin Hochner; Burton Yang; Hermona Soreq; Wei-Yang Lu
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 9.  Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Authors:  David G Wilkinson; Paul T Francis; Elias Schwam; Jennifer Payne-Parrish
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.

Authors:  Erez Podoly; Deborah E Shalev; Shani Shenhar-Tsarfaty; Estelle R Bennett; Einor Ben Assayag; Harvey Wilgus; Oded Livnah; Hermona Soreq
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.